Clinical Nutrition, Advanced Heart Failure/Mechanical Circulatory Support/Heart Transplant, Stanford Healthcare, Stanford, California, USA.
Critical Care Quality, Stanford Healthcare, Stanford, California, USA.
Nutr Clin Pract. 2022 Jun;37(3):677-697. doi: 10.1002/ncp.10854. Epub 2022 May 23.
Patients undergoing heart transplant (HT) and ventricular assist device (VAD) implant may experience intra- and postoperative complications requiring high-dose vasopressor agents and/or mechanical circulatory support. These complications increase the risk of nonocclusive bowel ischemia (NOBI) and inadequate enteral nutrition (EN) delivery, and guidance for this high-risk patient population is limited. To optimize nutrition support practices in this patient population at our institution, we created the High-Risk Nutrition Support Protocol (HRNSP) to improve nutrient delivery and promote safer EN practices in the setting of NOBI risk factors after HT and VAD implant.
We developed and implemented a nutrition support protocol as a quality improvement (QI) initiative. Data were obtained before (n = 62) and after (n = 52) protocol initiation. We compared nutrition and clinical outcomes between the pre- and post-intervention groups.
Fewer calorie deficits (P < 0.001), fewer protein deficits (P < 0.001), a greater proportion of calorie/protein needs met (P < 0.001), zero NOBI cases (0%), and decreased intensive care unit (ICU) length of stay (LOS) (P = 0.005) were observed with 100% (n = 52 of 54) HRNSP implementation success. Increased use of parenteral nutrition did not increase central line-associated bloodstream infections (P = 0.46). There was no difference in hospital LOS (P = 0.44) or 90-day and 1-year mortality (P = 0.56, P = 0.35).
This single-center, QI pre- and post-protocol intervention outcome study suggests that implementing and adhering to a nutrition support protocol for VAD implant/HT patients with hemodynamic complications increases nutrient delivery and is associated with reduced ICU LOS and NOBI.
接受心脏移植 (HT) 和心室辅助装置 (VAD) 植入的患者可能会经历术中及术后并发症,需要使用大剂量血管加压药物和/或机械循环支持。这些并发症增加了非闭塞性肠缺血 (NOBI) 和肠内营养 (EN) 输送不足的风险,针对这一高危人群的指导有限。为了优化我院这一高危人群的营养支持实践,我们制定了高危营养支持方案 (HRNSP),以改善 HT 和 VAD 植入后存在 NOBI 风险因素患者的营养输送,并促进更安全的 EN 实践。
我们制定并实施了营养支持方案,作为一项质量改进 (QI) 计划。在方案启动前 (n=62) 和启动后 (n=52) 分别获取数据。我们比较了干预前后两组的营养和临床结局。
实施 100% (n=52/54) HRNSP 后,营养摄入不足的情况明显减少 (P<0.001),蛋白质摄入不足的情况明显减少 (P<0.001),热量/蛋白质需求得到满足的比例更高 (P<0.001),未发生零例 NOBI (0%),重症监护病房 (ICU) 住院时间 (LOS) 缩短 (P=0.005)。肠外营养的使用增加并未导致中心静脉相关血流感染增加 (P=0.46)。住院 LOS 无差异 (P=0.44),90 天和 1 年死亡率也无差异 (P=0.56,P=0.35)。
这项单中心、QI 前后方案干预的研究结果表明,为存在血流动力学并发症的 VAD 植入/HT 患者实施并坚持营养支持方案,可增加营养输送,与 ICU LOS 缩短和 NOBI 减少相关。